Abstract:PURPOSE:Human telomeres, which are composed of long, repetitive sequences of TTAGGG and a variety of proteins, function as a protective structure capping the ends of chromosomes. Telomere dysfunction plays important roles in cancer initiation and progression. TRF1, TRF2, POT1, and RAP1 are four major telomere proteins that regulate telomere stability and telomere length. We hypothesized that the expression of these genes would have significant predictive value for cancer development and prognosis.EXPERIMENTAL DESIGN:We compared the mRNA expression level of TRF1, TRF2, POT1, and RAP1 between tumor and adjacent normal tissues from 148 patients with non-small cell lung cancer using real-time quantitative PCR. We then estimated the prognostic value of the mRNA expression of these genes in tumors.RESULTS:The expression level of TRF1 was significantly lower in tumor tissues than in adjacent normal tissues (P < 0.0001); no significant difference was found for TRF2, POT1, and RAP1. The expression of RAP1 gene in tumors was highly predictive of overall survival. In the Cox proportional hazards model, patients with higher RAP1 expression were associated with a significantly better survival [hazard ratio (HR), 0.47; 95% confidence interval (95% CI), 0.24-0.91]. This improved survival was more prominent in men (HR, 0.45; 95% CI, 0.22-0.996) and in ever smokers (HR, 0.50; 95% CI, 0.24-1.02). Kaplan-Meier survival curves showed that patients with higher RAP1 expression had significantly longer median survival than patients with lower expression (median = 51.21 versus 15.34 months, P < 0.0009). The expressions of TRF2 in tumor tissues were significantly correlated with tumor grades (P = 0.0114).CONCLUSIONS:RAP1 expression may be a useful biomarker of tumor progression and survival.

Expression Of Telomeric Repeat Binding Factor 1 Protein In Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

The Expression of Telomerase Activity in Patients with Non-Small Cell Lung Cancer

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

[Expression of Telomere Repeat Binding Factor 1 (TRF1) Protein in Kidney Cancer].

Study of Telomerase Activity in Pleural Lavage Fluid Specimens in Patients with Non-Small-cell Lung Cancer and Its Clinical Significance

Abnormal Expression and Clinical Significance of Telomeric Repeat Binding Factor 1 and Tankyrase 1 in Non-small Cell Lung Cancer

The Detectin of Telomerase Activity in Non-Small Cell Lung Cancer

[Expression of telomere binding factor 2 (TRF2) on leukemia cell lines and primary leukemia cells].

Telomerase Activity of Fibrobronchoscopic Brushing Cells in Non-Small Cell Lung Cancer

Expression of telomerase activity in human lung cancer.]

The expression of human antigen R and vascular endothelial growth factor-C and their significance in non-small cell lung cancer]

Expression of Telomerase Htert in Human Non-Small Cell Lung Cancer and Its Correlation with C-Myc Gene

[Telomerase Activity in Human Primary Lung Caner.].

Analysis of the Nuclear Localization Signal of TRF1 in Non-Small Cell Lung Cancer

[Relationship among Telomerase Activity, Telomerase RNA and Telomerase Catalytic Subunit Gene Expression and Their Significance in Non Small-Cell Lung Cancer].

Expressionof Telomere-AssociatedGenes As PrognosticMarkers for Overall Survival in Patients with Non ^ Small Cell Lung Cancer

Telomerase Activity in Human Primary Lung Cancer

[Expression of Human Telomere Repeat Binding Factor 1 (TRF1) in Acute Leukemia Cells and Its Correlation with Telomerase Activities].

Blood Telomerase Activity and Its Correlativity with Non-Small Cell Lung Carcinoma

Expression of Catalytic Subunit Gene Htert of Telomerase and Its Clinical Significance in Non-small Cell Lung Cancer

[Detection of Telomerase Activity Level in Human Non-Small-cell Lung Cancer].